Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
pchop123
(76.49)
Submitted: 5/9/2013 3:35:29 PM :
Start Price:
$98.37
ALXN Score:
-0.79
more upside now than downside
Recs
zzlangerhans
(99.77)
Submitted: 4/23/2013 7:58:05 PM :
Start Price:
$90.53
ALXN Score:
+3.33
I'm always a little late to the dip with Alexion because I can't shake the worry that they'll get the rug pulled out from under them a la Questcor. Their 18B market cap seems unimaginably large for a company that sells a single product to treat a rare disease. Most recently, I had the stock flagged for a green thumb at 85 and a real buy at ... probably never. But Portefeuille made it easy for me by directing a 100 share buy at 90.32 for the collaboration. Making real money on Alexion will make a nice counterpoint to have been pummeled by the stock on CAPS.
Recs
CarlosDK
(40.12)
Submitted: 1/10/2013 8:12:04 AM :
Start Price:
$100.68
ALXN Score:
+14.41
expensive on all valuations
Recs
jeffskopp
(< 20)
Submitted: 10/18/2012 6:34:28 PM :
Start Price:
$112.17
ALXN Score:
-25.73
best drug for what it heals
Recs
benyboy
(< 20)
Submitted: 7/19/2012 6:47:08 AM :
Start Price:
$108.68
ALXN Score:
-28.47
jim cramer likes it
Recs
ayuddha
(< 20)
Submitted: 7/15/2012 5:18:50 PM :
Start Price:
$96.87
ALXN Score:
-19.99
It was picked by www.hechtsoft.de Trade Alerts.
Recs
danrifenburgh
(< 20)
Submitted: 12/19/2011 1:25:55 PM :
Start Price:
$67.44
ALXN Score:
+10.41
After a 60% run-up, this volatile stock seems due for a fall. TM P/E of 82.96 with expected earnings growth of 31.54% taking it to a forward P/E of 38.81 next year. ALXN also trades at a premium to S&P500 TTM P/E. The PEG stands at 2.24, this could suggest some overvaluation. The Price/Book is 11.62.
Recs
rannici
(< 20)
Submitted: 10/27/2011 9:24:45 AM :
Start Price:
$67.84
ALXN Score:
+16.66
just following the trend...
Recs
SnowBawl
(< 20)
Submitted: 10/26/2011 8:10:48 AM :
Start Price:
$66.77
ALXN Score:
+15.57
Increasing sales and margins screen. (master list).
Recs
tradingblues1
(63.65)
Submitted: 10/13/2011 7:05:08 PM :
Start Price:
$68.08
ALXN Score:
+10.00
soaring to the moon!!
Recs
SIDRWC
(55.60)
Submitted: 9/28/2011 2:50:23 AM :
Start Price:
$67.62
ALXN Score:
+6.20
The long-term potential growth for this company is astronomical... They seem to have incredible moment at this point, and is closely linked to stock-market turbulence. Very excited for this companies potential, and am buying in for the long hall.
Recs
Jonock
(< 20)
Submitted: 8/29/2011 3:02:33 PM :
Start Price:
$56.88
ALXN Score:
+37.89
Generic dtugs
Recs
Recs
mrindependent
(75.73)
Submitted: 11/24/2010 1:30:43 PM :
Start Price:
$38.21
ALXN Score:
-122.90
Found this stock with a screen that looks for stocks that are stratospherically valued based on high expectations. CAPS score of 2 is higher than expected, which indicates that somebody likes this stock at this price. The deciding factor for me was the negative commentary from ZZLangerhans.
Recs
CramersSkeeDaddy
(98.06)
Submitted: 10/13/2010 12:01:39 PM :
Start Price:
$34.08
ALXN Score:
+152.26
biotech spec 3
Recs
Witchdoctor78
(59.86)
Submitted: 9/11/2010 10:06:30 PM :
Start Price:
$30.46
ALXN Score:
+180.12
Upcommimg biotech with a first in class drug due to expand its fda indications. They have pricing power, an off the beaten path pipeline, international presence and good marketing reach in the US. They face no competition for their indications, think Genzyme, only more focused. Could be an acquisition too.
Recs
jbs4radio
(70.46)
Submitted: 6/26/2009 1:19:38 AM :
Start Price:
$22.46
ALXN Score:
+283.14
Russell 2000 long term growth 31-173%
Recs
kodiakcap
(97.51)
Submitted: 4/14/2009 3:06:12 PM :
Start Price:
$17.95
ALXN Score:
+358.00
earnings
Recs
enuresis
(90.00)
Submitted: 4/7/2009 5:53:07 PM :
Start Price:
$17.69
ALXN Score:
+359.92
eps is growing rapidly. good roe.
Recs
maggioli
(62.00)
Submitted: 4/1/2009 3:17:30 PM :
Start Price:
$18.31
ALXN Score:
+336.83
All you need to do is wait, Japan will be on board in 2010. Earnings will just keep growing for the next two years. No matter the economy. During this time just relax and wait for the stock to go up.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 35 : 1 2 Next »